Prognosis factors in pT3 renal cell carcinoma;Factores pronóstico en carcinoma renal pT3

Actas Urologicas Espanolas

Volumn 27, Issue 1, 2003, Pages 26-32

  Sanchez Zalabardo D ^a   Arocena Garcia Tapia J ^a   Regojo Balboa, J M ^a   Fernandez Montero J M ^a   Lopez Ferrandis J ^a   Rosell Costa, D ^a   Robles Garcia J E ^a   Zudaire Bergera, J J ^a   Berian Polo J M ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Prognosis factors; PT3; Renal cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SIZE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PREDICTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

EID: 0037235981     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(03)72872-1     Document Type: Article

References (35)

1. NAGASHIMA Y,: Chromophobe renal cell carcinoma: clinical, pathological and molecular biological aspects. Pathol Int 2000; 50 (11): 872-878.
2. KE-HUNG TSUI, OLEG SHVARTS, SMITH ROBERT B et al.: Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000; 163: 426-430.
3. RUSSO P.: Renals cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol 2000; 27 (2): 160-176.
4. HOCK LM, LYNCH J, BALAJI KC: Increasing incidence of all stages of kidney cancer in the las decades in the united states: an analysis of surveillance, epidemiology and results program data. J Urol 2002; 167: 57-60.
5. KHADRA MH, PICKARD RS, CHARLTON M, POWEL PG, NEAL DE: A prospective analysis of 1930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000; 163: 524-527.
6. GUINAN P, SOBIN LH, ALGABA F et al.: TNM staging of renal cell carcinoma. Cancer 1997; 80: 992-993.
7. FICARRA V, RIGHETTI R, PILLONI S et al.: Prognostic factors in patients with renal cell carcinoma: retrospective analisis of 675 cases. Eur Urol 2002; 41: 190-198.
8. TSUI K, SHVARTS O, SMITH RB et al.: Prognostic indicators for renal carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000; 163: 1.090-1.095.
9. GELB AB.: Renal cell carcinoma. Current prognostic factors. Cancer 1997; 80: 981-986.
10. GUTIÉRREZ JL, VAL-BERNAL JF, GARIJO MF, BUELTA L, PORTILLO JA.: Nuclear morphometry in prognosis of renal adenocarcinoma. Urology 1992; 39 (2): 130-134.
11. RUIZ JL, HERNÁNDEZ M, MARTÍNEZ J, VERA C, JIMÉNEZ-CRUZ JF.: Value of morphometry as an independent prognostic factor in renal cell carcinoma. Eur Urol 1995; 27 (1): 54-57.
12. RUIZ CERDÁ JL, HERNÁNDEZ M, GOMIS F y cols.: Value of deoxyribonucleic acid ploidy and nuclear morphometry for prediction of disease progression in renal cell carcinoma. J Urol 1996; 155 (2): 459-465.
13. RUIZ CERDÁ JL, HERNÁNDEZ M, SEMPERE A y cols.: Intratumoral heterogeneity of DNA content in renal cell carcinoma and its prognostic significance. Cancer 1999; 15; 86 (4): 664-671.
14. BERNUES M, CASADEVALL C, MIRO R et al.: Analysis of 3p allelic losses in renal cell carcinomas: comparison with cytogenetic results. Cancer Genet Cytogenet 1998; 107 (2): 121-124.
15. GIRGIN C, TARHAN H, HEKIMGIL M, SEZER A, GUREL G: p53 mutations and other prognostic factors of renal cell carcinoma. Urol Int 2001; 66 (2): 78-83.
16. LJUNGBERG B, BOZOKY B, KOVACS G et al.: p53 expression in correlation to clinical outcome in patients with renal cell carcinoma. Scand J Urol Nephrol 2001; 35: 15-20.
17. DANIEL L, LECHEVALLIER E, GIORGI R et al.: CD44s and CD44v6 expression in localized T1-T2 conventional renal cell carcinomas. J Pathol 2001: 193 (3): 345-349.
18. DE ÁLAVA E, PANIZO A, SOLA I, RODRÍGUEZ-RUBIO FI, PARDO-MINDÁN FJ.: CD44v6 expression is related to progression in renal epithelial tumours. Histopathology 1998; 33 (1): 39-45.
19. NAKANO O, SATO M, NAITO Y et al.: Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61 (13): 5.132-5.136.
20. PARADIS V, LAGHA NB, ZEIMOURA L et al.: Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000; 436 (4): 351-356.
21. SEVINC M, KIRKALI Z, YORUKOGLU K, MUNGAN U, SADE M.: Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol 2000; 38 (6): 728-733.
22. LANG H, LINDNER V, SAUSSINE C et al.: Microscopic venous invasion: a prognostic factor in renal cell carcinoma. Eur Urol 2000; 38 (5): 600-605.
23. ZHOU M, RUBIN MA.: Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Semin Urol Oncol 2001; 19: 80-87.
24. CONGREGADO RUIZ B, MEDINA LÓPEZ RA, SÁNCHEZ GÓMEZ E, MORALES LÓPEZ A, PASCUAL DEL POBIL JL.: Diagnóstico incidental del carcinoma renal. ¿Implica mejor pronóstico?. Actas Urol Esp 2001; 25: 278-282.
25. GOLDSTEIN NS.: The current state of renal cell carcinoma grading. Cancer 1997; 80: 1.977-1.980.
26. MINERVINI A, LILAS L, MINERVINI R, M.D., SELLI C.: Prognostic value of nuclear grading in patients with intracapsular (pT1-pT2) renal cell carcinoma. Cancer 2002; 94 (10): 2.590-2.599.
27. CHEVILLE JC, BLUTE ML, ZINCKE H, LOHSE CM, WEAVER AL.: Stage pT1 conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival. J Urol 2001; 166 (2): 453-456.
28. STRÖRKEL S, EBLE JN, ADLAKHA K et al.: Clasification of renal cell carcinoma. Cancer 1997; 80: 987-989.
29. LJUNGBERG B, ALAMDARI FI, STENLING R, ROOS G.: Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 1999; 36 (6): 565-569.
30. SANZ PÉREZ G, AROCENA GARCÍA-TAPIA J, ZUDAIRE BERGERA JJ y cols,: Carcinoma cromófobo de riñón. Actas Urol Esp 1999; 23 (4): 323-326.
31. BIELSA O, LLORETA J, GELABERT-MAS A.: Cystic renal cell carcinoma: pathological features, survival and implications for treatment. Br J Urol 1998; 82 (1): 16-20.
32. LLORETA J, COROMINAS JM, MUNNE A, DOMÍNGUEZ D, BIELSA O, GELABERT A, SERRANO S.: Low-grade spindle cell carcinoma of the kidney. Ultrastruct Pathol 1998; 22 (1): 83-90.
33. FICARRA V, RIGHETTI R, D'AMICO A et al.: Renal vein and vena cava involvement does not affect prognosis in patients with renal cell carcinoma. Oncology 2001; 61 (1): 10-15.
34. SÁNCHEZ DE LA MUELA P, ZUDAIRE JJ, ROBLES JE y cols.: Renal cell carcinoma: vena caval invasion and prognosis factors. Eur Urol 1991; 19 (4): 284-290.
35. SÁNCHEZ DE LA MUELA P, ZUDAIRE BERGERA JJ, ROBLES GARCÍA JE y cols.: Análisis de supervivencia en carcinoma renal con invasión de la cava. Actas Urol Esp 1991; 15 (3): 247-252.